Synmosa Biopharma Corporation (TPEX:4114)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
34.60
+0.30 (0.87%)
Jun 6, 2025, 1:30 PM CST

Synmosa Biopharma Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
5,7165,5505,1404,3863,2353,038
Upgrade
Revenue
5,7165,5505,1404,3863,2353,038
Upgrade
Revenue Growth (YoY)
10.67%7.96%17.19%35.59%6.47%13.37%
Upgrade
Cost of Revenue
3,2443,1493,0212,5601,9501,905
Upgrade
Gross Profit
2,4722,4012,1201,8271,2851,133
Upgrade
Selling, General & Admin
1,4501,4021,2871,148883.58817.24
Upgrade
Research & Development
253.32259.72210.91215.28214.37159.53
Upgrade
Other Operating Expenses
-0.24-----2
Upgrade
Operating Expenses
1,7001,6601,5031,3661,099983.56
Upgrade
Operating Income
771.49740.97616.81460.71186.74149.51
Upgrade
Interest Expense
-58.56-58.1-67.19-59.5-51.97-52.82
Upgrade
Interest & Investment Income
24.8525.4516.327.183.434.26
Upgrade
Earnings From Equity Investments
-13.43-13.78-10.33-16.56-16.4-1.54
Upgrade
Currency Exchange Gain (Loss)
11.5811.582.568.990.82.84
Upgrade
Other Non Operating Income (Expenses)
-67.97-46.7123.0249.7111.66-4.1
Upgrade
EBT Excluding Unusual Items
667.96659.41581.2450.53134.2598.14
Upgrade
Impairment of Goodwill
---8.79-7.27-6-7.54
Upgrade
Gain (Loss) on Sale of Investments
--30.512.574.72247
Upgrade
Gain (Loss) on Sale of Assets
-0.44-0.440.92281.7211.860.68
Upgrade
Asset Writedown
-0.24-0.24-2.07-7.95-2.21-36.79
Upgrade
Other Unusual Items
0.340.34-0.2-4.5911.26196.16
Upgrade
Pretax Income
667.62659.07601.56725.01153.89497.65
Upgrade
Income Tax Expense
185.63190.19196.39106.1337.8123.04
Upgrade
Earnings From Continuing Operations
482468.88405.17618.89116.08474.6
Upgrade
Minority Interest in Earnings
228.08215.8189.66180.21187.79163.51
Upgrade
Net Income
710.08684.68594.83799.09303.86638.11
Upgrade
Net Income to Common
710.08684.68594.83799.09303.86638.11
Upgrade
Net Income Growth
9.18%15.10%-25.56%162.98%-52.38%1255.09%
Upgrade
Shares Outstanding (Basic)
422420406391394384
Upgrade
Shares Outstanding (Diluted)
424422407392395386
Upgrade
Shares Change (YoY)
2.15%3.52%3.84%-0.79%2.35%9.76%
Upgrade
EPS (Basic)
1.681.631.462.040.771.66
Upgrade
EPS (Diluted)
1.671.621.462.040.771.65
Upgrade
EPS Growth
6.40%10.96%-28.31%166.09%-53.73%1135.07%
Upgrade
Free Cash Flow
625.03566.1304.89500.95361.81100
Upgrade
Free Cash Flow Per Share
1.471.340.751.280.920.26
Upgrade
Dividend Per Share
--0.5450.4990.3830.202
Upgrade
Dividend Growth
--9.30%30.35%89.37%-
Upgrade
Gross Margin
43.25%43.26%41.24%41.64%39.73%37.29%
Upgrade
Operating Margin
13.50%13.35%12.00%10.50%5.77%4.92%
Upgrade
Profit Margin
12.42%12.34%11.57%18.22%9.39%21.00%
Upgrade
Free Cash Flow Margin
10.94%10.20%5.93%11.42%11.18%3.29%
Upgrade
EBITDA
1,1051,076927.91760.78477.09437.99
Upgrade
EBITDA Margin
19.33%19.39%18.05%17.34%14.75%14.42%
Upgrade
D&A For EBITDA
333.21335.39311.1300.08290.35288.48
Upgrade
EBIT
771.49740.97616.81460.71186.74149.51
Upgrade
EBIT Margin
13.50%13.35%12.00%10.50%5.77%4.92%
Upgrade
Effective Tax Rate
27.80%28.86%32.65%14.64%24.57%4.63%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.